| PERIOD ENDING | 2-Jan-09 | 28-Dec-07 | 29-Dec-06 | | Total Revenue | 546,644 | 318,746 | 271,142 | | Cost of Revenue | 390,855 | 202,721 | 168,698 | | | Gross Profit | 155,789 | 116,025 | 102,444 | | | Operating Expenses | | Research Development | 31,444 | 29,914 | 24,225 | | Selling General and Administrative | 72,633 | 44,674 | 55,843 | | Non Recurring | 16,818 | 16,093 |
-
| | Others |
-
| 5,324 |
-
| | | | Total Operating Expenses |
-
| 96,005 |
-
| | | | Operating Income or Loss | 34,894 | 20,020 | 22,376 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,577 | 15,971 | 5,763 | | Earnings Before Interest And Taxes | 40,471 | 35,991 | 28,139 | | Interest Expense | 13,168 | 7,303 | 4,605 | | Income Before Tax | 27,303 | 28,688 | 23,534 | | Income Tax Expense | 8,744 | 13,638 | 7,408 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,559 | 15,050 | 16,126 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 18,559 | 15,050 | 16,126 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,559 | $15,050 | $16,126 |
|
1.48% Nasdaq 
Income Statement
